Literature DB >> 26867895

Erratum. A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927).

Gregory M M Videtic, Chen Hu, Anurag K Singh, Joe Y Chang, William Parker, Kenneth R Olivier, Steven E Schild, Ritsuko Komaki, James J Urbanic, Hak Choy.   

Abstract

Entities:  

Year:  2016        PMID： 26867895     DOI： 10.1016/j.ijrobp.2015.11.031

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  17 in total

Review 1.  Lung Stereotactic Body Radiation Therapy.

Authors:  Sana Rehman; Michael C Roach; Jeffrey D Bradley; Cliff G Robinson
Journal:  Mo Med       Date:  2015 Sep-Oct

2.  Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: A review from NRG oncology.

Authors:  Edward D Brandner; Indrin J Chetty; Tawfik G Giaddui; Ying Xiao; M Saiful Huq
Journal:  Med Phys       Date:  2017-04-20       Impact factor: 4.071

3.  Evaluation of a template-based algorithm for markerless lung tumour localization on single- and dual-energy kilovoltage images.

Authors:  Alec M Block; Rakesh Patel; Murat Surucu; Matthew M Harkenrider; John C Roeske
Journal:  Br J Radiol       Date:  2016-10-12       Impact factor: 3.039

4.  Perspectives on stereotactic body radiotherapy for early-stage non-small cell lung cancer: a maturing treatment modality.

Authors:  Chunhui Han
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?

Authors:  Rameses Sroufe; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 6.  Plan evaluation indices: A journey of evolution.

Authors:  Ganeshkumar Patel; Abhijit Mandal; Sunil Choudhary; Ritusha Mishra; Ravindra Shende
Journal:  Rep Pract Oncol Radiother       Date:  2020-03-04

7.  Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study.

Authors:  Benjamin Mou; Chris J Beltran; Sean S Park; Kenneth R Olivier; Keith M Furutani
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

8.  To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer.

Authors:  Joshua Kim; Qixue Wu; Bo Zhao; Ning Wen; Munther Ajlouni; Benjamin Movsas; Indrin J Chetty
Journal:  Radiat Oncol       Date:  2016-09-22       Impact factor: 3.481

9.  Improving Delivery Accuracy of Stereotactic Body Radiotherapy to a Moving Tumor Using Simplified Volumetric Modulated Arc Therapy.

Authors:  Young Eun Ko; Byungchul Cho; Su Ssan Kim; Si Yeol Song; Eun Kyung Choi; Seung Do Ahn; Byongyong Yi
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

10.  Helical Therapy is Safe for Lung Stereotactic Body Radiation Therapy Despite Limitations in Achieving Sharp Dose Gradients.

Authors:  Neha P Amin; Adrian Nalichowski; Shauna Campbell; Jal Hyder; Robyn Spink; Andre A Konski; Michael Dominello
Journal:  Technol Cancer Res Treat       Date:  2017-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.